298 related articles for article (PubMed ID: 30987250)
21. Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor.
Kato H; Sekine Y; Furuya Y; Miyazawa Y; Koike H; Suzuki K
Biochem Biophys Res Commun; 2015 May; 461(1):115-21. PubMed ID: 25862373
[TBL] [Abstract][Full Text] [Related]
22. Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.
Patel BB; Gupta D; Elliott AA; Sengupta V; Yu Y; Majumdar AP
Anticancer Res; 2010 Feb; 30(2):319-25. PubMed ID: 20332435
[TBL] [Abstract][Full Text] [Related]
23. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
24. Dendrosomal curcumin inhibits metastatic potential of human SW480 colon cancer cells through Down-regulation of Claudin1, Zeb1 and Hef1-1 gene expression.
Dehghan Esmatabadi MJ; Farhangi B; Safari Z; Kazerooni H; Shirzad H; Zolghadr F; Sadeghizadeh M
Asian Pac J Cancer Prev; 2015; 16(6):2473-81. PubMed ID: 25824783
[TBL] [Abstract][Full Text] [Related]
25. Metformin Inhibited Proliferation and Metastasis of Colorectal Cancer and presented a Synergistic Effect on 5-FU.
Sang J; Tang R; Yang M; Sun Q
Biomed Res Int; 2020; 2020():9312149. PubMed ID: 32851092
[TBL] [Abstract][Full Text] [Related]
26. Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.
Iida M; Tsuboi K; Niwa T; Ishida T; Hayashi SI
Breast Cancer; 2019 May; 26(3):272-281. PubMed ID: 30328006
[TBL] [Abstract][Full Text] [Related]
27. Curcumin may reverse 5-fluorouracil resistance on colonic cancer cells by regulating TET1-NKD-Wnt signal pathway to inhibit the EMT progress.
Lu Y; Zhang R; Zhang X; Zhang B; Yao Q
Biomed Pharmacother; 2020 Sep; 129():110381. PubMed ID: 32887024
[TBL] [Abstract][Full Text] [Related]
28. The molecular mechanisms of curcumin's inhibitory effects on cancer stem cells.
Zendehdel E; Abdollahi E; Momtazi-Borojeni AA; Korani M; Alavizadeh SH; Sahebkar A
J Cell Biochem; 2019 Apr; 120(4):4739-4747. PubMed ID: 30269360
[TBL] [Abstract][Full Text] [Related]
29. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
Su P; Yang Y; Wang G; Chen X; Ju Y
Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
[TBL] [Abstract][Full Text] [Related]
30. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
31. [Relationship between the insulin-like growth factor 1 receptor signaling pathway and the resistance of nasopharyngeal carcinoma to cetuximab].
Zuo Q; Luo RC
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):575-9. PubMed ID: 21122407
[TBL] [Abstract][Full Text] [Related]
32. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription.
Liu Q; Loo WT; Sze SC; Tong Y
Phytomedicine; 2009 Oct; 16(10):916-22. PubMed ID: 19524420
[TBL] [Abstract][Full Text] [Related]
33. The potentiation of curcumin on insulin-like growth factor-1 action in MCF-7 human breast carcinoma cells.
Xia Y; Jin L; Zhang B; Xue H; Li Q; Xu Y
Life Sci; 2007 May; 80(23):2161-2169. PubMed ID: 17499312
[TBL] [Abstract][Full Text] [Related]
34. Berberine inhibits proliferation and migration of colorectal cancer cells by downregulation of GRP78.
Gong C; Hu X; Xu Y; Yang J; Zong L; Wang C; Zhu J; Li Z; Lu D
Anticancer Drugs; 2020 Feb; 31(2):141-149. PubMed ID: 31743135
[TBL] [Abstract][Full Text] [Related]
35. Copper supplementation amplifies the anti-tumor effect of curcumin in oral cancer cells.
Lee HM; Patel V; Shyur LF; Lee WL
Phytomedicine; 2016 Nov; 23(12):1535-1544. PubMed ID: 27765374
[TBL] [Abstract][Full Text] [Related]
36. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
[TBL] [Abstract][Full Text] [Related]
37. Leptocarpin Suppresses Proliferation, Migration, and Invasion of Human Osteosarcoma by Targeting Type-1 Insulin-Like Growth Factor Receptor (IGF-1R).
Zheng SW; Wan WG; Miao HX; Tang R; Wang B; Huang QZ; Liu WL; Zheng JP; Chen CQ; Zhong HB; Li SF; Sun CH
Med Sci Monit; 2017 Aug; 23():4132-4140. PubMed ID: 28844074
[TBL] [Abstract][Full Text] [Related]
38. Evidence That Calebin A, a Component of
Buhrmann C; Popper B; Kunnumakkara AB; Aggarwal BB; Shakibaei M
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31805741
[TBL] [Abstract][Full Text] [Related]
39. Curcumin exhibits anti-tumor effect and attenuates cellular migration via Slit-2 mediated down-regulation of SDF-1 and CXCR4 in endometrial adenocarcinoma cells.
Sirohi VK; Popli P; Sankhwar P; Kaushal JB; Gupta K; Manohar M; Dwivedi A
J Nutr Biochem; 2017 Jun; 44():60-70. PubMed ID: 28402926
[TBL] [Abstract][Full Text] [Related]
40. The effect of forced expression of mutated K-RAS gene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy.
Matsunaga Y; Adachi Y; Sasaki Y; Koide H; Motoya M; Nosho K; Takagi H; Yamamoto H; Sasaki S; Arimura Y; Tokino T; Carbone DP; Imai K; Shinomura Y
Mol Carcinog; 2017 Feb; 56(2):515-526. PubMed ID: 27312358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
